SELLAS Life Sciences Grou... (SLS)
1.21
0.03 (2.54%)
At close: Mar 03, 2025, 12:50 PM
SELLAS Life Sciences Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 |
| Revenue | n/a | 1M | 7.6M | 1.9M | n/a | n/a | n/a | n/a | n/a | 9.32M | 2.49M | 2.04M | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | 100K | 200K | n/a | n/a | n/a | n/a | 3K | 355K | 1.4M | 520K | n/a | 20.79M | n/a | n/a | n/a | 11.41M | n/a |
| Gross Profit | n/a | 900K | 7.4M | 1.9M | n/a | n/a | n/a | -3K | -355K | 7.92M | 1.97M | 2.04M | -20.79M | n/a | n/a | n/a | -11.41M | n/a |
| Operating Income | -37.87M | -41.95M | -25.29M | -16.98M | -20.04M | -31.09M | -23.04M | -31.87M | -34.22M | -52.22M | -33.84M | -21.2M | -20.79M | -16.63M | -17.52M | -14.55M | -11.41M | -2.4M |
| Interest Income | 525K | 317K | 6K | 26K | 118K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 180K | 448K | n/a |
| Pretax Income | -37.34M | -41.3M | -20.94M | -16.77M | -19.37M | -29.05M | -23.5M | -10.86M | -38.59M | -36.61M | -75.63M | -34.38M | -11.48M | -11.99M | -18.39M | -14.37M | -10.96M | -2.4M |
| Net Income | -37.34M | -40.65M | -20.7M | -16.76M | -19.29M | -27.67M | -23.75M | -23.55M | -63.9M | -36.61M | -76.68M | -34.97M | -11.48M | -11.99M | -18.39M | -14.37M | -10.99M | -2.4M |
| Selling & General & Admin | 13.86M | 12.58M | 11.32M | 9.6M | 9.92M | 12.77M | 15.09M | 12.01M | 10.61M | 31.34M | 14.6M | 6.58M | 9.25M | 8.75M | 8.63M | 7.5M | 4.67M | 633K |
| Research & Development | 24.01M | 30.27M | 21.37M | 9.28M | 7.29M | 18.32M | 6.07M | 19.86M | 23.61M | 28.35M | 21.08M | 14.61M | 11.54M | 7.87M | 8.89M | 7.05M | 6.75M | 1.3M |
| Other Expenses | n/a | 10M | 5.7M | n/a | n/a | -3.03M | n/a | n/a | 509K | 170K | 37K | -13.18M | 9.25M | n/a | n/a | 7.5M | n/a | n/a |
| Operating Expenses | 37.87M | 42.85M | 32.69M | 18.88M | 17.21M | 31.09M | 21.16M | 31.87M | 34.22M | 60.14M | 35.81M | 21.2M | 20.79M | 16.63M | 17.52M | 14.55M | 11.41M | 2.4M |
| Interest Expense | n/a | n/a | n/a | n/a | 118K | 266K | 462K | 3.51M | 760K | 1.11M | 807K | 33K | n/a | 5K | -5K | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.39M | n/a | n/a | 2.63M | 931K | n/a |
| Cost & Expenses | 37.87M | 42.95M | 32.89M | 18.88M | 17.21M | 31.09M | 21.16M | 31.87M | 34.22M | 61.54M | 36.33M | 21.2M | 20.79M | 16.63M | 17.52M | 14.55M | 11.41M | 2.4M |
| Income Tax | n/a | -649K | -237K | -17K | -81K | -1.38M | 253K | 243K | 365K | -15.45M | 1.05M | -1.05M | -9.3M | -4.63M | 867K | n/a | 25K | n/a |
| Shares Outstanding (Basic) | 27.78M | 19.4M | 15.48M | 7.98M | 2.56M | 261.54K | 46.81K | 6.64K | 5.17K | 3.98K | 3.01K | 2.08K | 1.21K | 612.00 | 540.00 | 458.00 | 422.00 | 420.00 |
| Shares Outstanding (Diluted) | 27.78M | 19.4M | 15.48M | 7.98M | 2.56M | 261.54K | 46.81K | 6.64K | 5.17K | 3.98K | 3.01K | 2.08K | 1.21K | 612.00 | 540.00 | 458.00 | 422.00 | 420.00 |
| EPS (Basic) | -1.34 | -2.1 | -1.34 | -2.1 | -7.54 | -105.8 | -507.49 | -3.55K | -12.35K | -9.2K | -25.51K | -16.8K | -9.48K | -19.6K | -34.05K | -31.38K | -26.04K | -5.73K |
| EPS (Diluted) | -1.34 | -2.1 | -1.34 | -2.1 | -7.54 | -105.8 | -507.49 | -3.55K | -12.35K | -9.2K | -25.51K | -16.8K | -9.48K | -19.6K | -34.05K | -31.38K | -26.04K | -5.73K |
| EBITDA | 529K | -31.95M | -19.66M | -16.4M | 668K | n/a | -23.04M | -15.98M | -37.48M | -36.61M | 7.63M | -34.38M | -11.32M | -11.82M | -18.22M | -14.24M | -10.93M | -2.4M |
| Depreciation & Amortization | 37.87M | 457K | 1.27M | 377K | 17.21M | 22.04M | 3K | 3K | 355K | 440K | 452K | 49K | 163K | 172K | 162K | 131K | 36K | n/a |